Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimmune Effects of Acute Morphine
NCT03801629Phase 1Completed
- Sponsor
- Yale University
- Start
- Sep 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of morphine in pain (2 arms), sponsored by Yale University. Primary endpoint: Change in Brain TSPO availability at 2 hours. Started Sep 2019; status: completed.
02
Drugs
morphine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03801629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03801629.